Top

World Journal of Urology

Published in:

01-02-2013 | Original Article

Mapping the cytokine profile of painful bladder syndrome/interstitial cystitis in human bladder and urine specimens

Authors: Anthony T. Corcoran, Naoki Yoshimura, Vikas Tyagi, Bruce Jacobs, Wendy Leng, Pradeep Tyagi

Published in: World Journal of Urology | Issue 1/2013

Abstract

Purpose

This study investigated the cytokine profile in bladder tissue and urine of painful bladder syndrome/interstitial cystitis (PBS/IC) patients.

Methods

Multiplex analysis of 23 cytokines was performed with a multiple antigen bead assay (Luminex 100 IS) on cold cup bladder biopsy and urine specimens collected during cystoscopy with hydrodistention (HD) under general anesthesia from 10 PBS/IC patients (ICS definition). Collected tissue specimens and urine from pre-HD and post-HD (mean 27 days) were compared to banked urine and tissue specimens (n = 10) collected from control subjects without PBS/IC symptoms.

Results

Univariate comparison of bladder tissue levels found significant elevation of IL-16, IL-18, CTACK, ICAM-1, MCP-3, SCGFβ, TRAIL, and VCAM-1 in PBS/IC relative to controls. Multivariate analysis revealed VCAM-1 and ICAM-1 were responsible for the discrimination of both tissue and urine of PBS/IC from controls. Urine levels of MCP-3 and TRAIL were significantly reduced a month after HD in concert with improvement in standardized measures of clinical symptoms (pain, urgency, and frequency (PUF) overall score [mean 25.8 ± 5.5 vs. 20.3 ± 7, p = 0.04] and symptom score [mean 18.2 ± 3.2 vs. 12.2 ± 5.9; p = 0.009]). Post-HD urine levels of MCSF(r = 0.88; p = 0.003), MCP-3 (r = 0.81; p = 0.01), SDF1α (r = 0.82; p = 0.01), and IL-18 (r = 0.64; p = 0.08) positively correlated with improved symptom scores.

Conclusions

These results indicate significant elevation of cytokines in PBS/IC bladder tissue relative to controls. Significant reduction in post-HD urine levels of MCP-3 and TRAIL relative to pre-HD in PBS/IC was associated with clinical improvement (as measured by PBS/IC symptom scores) to qualify them as biomarker candidates.

Erickson DR, Xie SX, Bhavanandan VP, Wheeler MA, Hurst RE, Demers LM et al (2002) A comparison of multiple urine markers for interstitial cystitis. J Urol 167:2461–2469PubMedCrossRef

Ogawa T, Homma T, Igawa Y, Seki S, Ishizuka O, Imamura T et al (2010) CXCR3 binding chemokine and TNFSF14 over expression in bladder urothelium of patients with ulcerative interstitial cystitis. J Urol 183:1206–1212PubMedCrossRef

Brewer ME, White WM, Klein FA, Klein LM, Waters WB (2007) Validity of pelvic pain, urgency, and frequency questionnaire in patients with interstitial cystitis/painful bladder syndrome. Urology 70:646–649PubMedCrossRef

Tyagi P, Barclay D, Zamora R, Yoshimura N, Peters K, Vodovotz Y et al (2010) Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study. Int Urol Nephrol 42:629–635PubMedCrossRef

George SK, Dipu MT, Mehra UR, Singh P, Verma AK, Ramgaokar JS (2006) Improved HPLC method for the simultaneous determination of allantoin, uric acid and creatinine in cattle urine. J Chromatogr, B: Anal Technol Biomed Life Sci 832:134–137CrossRef

Smaldone MC, Vodovotz Y, Tyagi V, Barclay D, Philips BJ, Yoshimura N et al (2009) Multiplex analysis of urinary cytokine levels in rat model of cyclophosphamide-induced cystitis. Urology 73:421–426PubMedCrossRef

Zhang Z, Cherryholmes G, Mao A, Marek C, Longmate J, Kalos M et al (2008) High plasma levels of MCP-1 and eotaxin provide evidence for an immunological basis of fibromyalgia. Exp Biol Med (Maywood) 233:1171–1180CrossRef

Bouchelouche K, Alvarez S, Andersen L, Nordling J, Horn T, Bouchelouche P (2004) Monocyte chemoattractant protein-1 production by human detrusor smooth muscle cells. J Urol 171:462–466PubMedCrossRef

Tyagi P, Killinger K, Tyagi V, Nirmal J, Peters K (2012) Urinary chemokines as Non-Invasive predictors of Ulcerative interstitial cystitis. J Urol 187:1275–1279CrossRef

10.

Malaviya R, Ikeda T, Ross E, Abraham SN (1996) Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 381:77–80PubMedCrossRef

11.

Dodd LG, Tello J (1998) Cytologic examination of urine from patients with interstitial cystitis. Acta Cytol 42:923–927PubMedCrossRef

12.

Kutlu O, Akkaya E, Koksal IT, Bassorgun IC, Ciftcioglu MA, Sanlioglu S et al (2010) Importance of TNF-related apoptosis-inducing ligand in pathogenesis of interstitial cystitis. Int Urol Nephrol 42:393–399PubMedCrossRef

13.

Wei W, Wang D, Shi J, Xiang Y, Zhang Y, Liu S et al (2010) Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induces chemotactic migration of monocytes via a death receptor 4-mediated RhoGTPase pathway. Mol Immunol 47:2475–2484PubMedCrossRef

14.

McGrath EE, Marriott HM, Lawrie A, Francis SE, Sabroe I, Renshaw SA et al (2011) TNF-related apoptosis-inducing ligand (TRAIL) regulates inflammatory neutrophil apoptosis and enhances resolution of inflammation. J Leukoc Biol 90:855–865PubMedCrossRef

15.

Rosevear HM, Lightfoot AJ, O’Donnell MA, Griffith TS (2009) The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette-Guerin (BCG) immunotherapy for urothelial carcinoma of the bladder. Cancer Metastasis Rev 28:345–353PubMedCrossRef

16.

Ottem DP, Teichman JM (2005) What is the value of cystoscopy with hydrodistension for interstitial cystitis? Urology 66:494–499PubMedCrossRef

17.

Chai TC, Zhang CO, Shoenfelt JL, Johnson HW Jr, Warren JW, Keay S (2000) Bladder stretch alters urinary heparin-binding epidermal growth factor and antiproliferative factor in patients with interstitial cystitis. J Urol 163:1440–1444PubMedCrossRef

18.

Liu HT, Tyagi P, Chancellor MB, Kuo HC (2009) Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment. BJU Int 104:1476–1481PubMedCrossRef

Title: Mapping the cytokine profile of painful bladder syndrome/interstitial cystitis in human bladder and urine specimens
Authors: Anthony T. Corcoran
Naoki Yoshimura
Vikas Tyagi
Bruce Jacobs
Wendy Leng
Pradeep Tyagi
Publication date: 01-02-2013
Publisher: Springer-Verlag
Published in: World Journal of Urology / Issue 1/2013
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-012-0852-y

2024 ASCO Annual Meeting

Springer Medicine

Mapping the cytokine profile of painful bladder syndrome/interstitial cystitis in human bladder and urine specimens

Abstract

Purpose

Methods

Results

Conclusions

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2013

Which clinical risk factors determine a pathological urodynamic evaluation in patients with multiple sclerosis? an analysis of 100 prospective cases

Oncologic outcomes obtained after neoadjuvant and adjuvant chemotherapy for the treatment of urothelial carcinomas of the upper urinary tract: a review

Significance of ADC value for detection and characterization of urothelial carcinoma of upper urinary tract using diffusion-weighted MRI

Comparing how significantly the pharmacological treatment of genitourinary cancer in a non-curative setting affects endpoints of survival or response

Oncologic outcomes obtained after laparoscopic, robotic and/or single port nephroureterectomy for upper urinary tract tumours

Brain penetration of the OAB drug trospium chloride is not increased in aged mice